Varex Imaging Corporation (VREX)
| Market Cap | 505.97M |
| Revenue (ttm) | 854.40M |
| Net Income (ttm) | -67.70M |
| Shares Out | 41.92M |
| EPS (ttm) | -1.63 |
| PE Ratio | n/a |
| Forward PE | 13.52 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 213,453 |
| Open | 12.68 |
| Previous Close | 12.71 |
| Day's Range | 11.74 - 12.77 |
| 52-Week Range | 6.76 - 14.57 |
| Beta | 1.00 |
| Analysts | Strong Buy |
| Price Target | 16.67 (+38.11%) |
| Earnings Date | May 7, 2026 |
About VREX
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products... [Read more]
Financial Performance
In fiscal year 2025, Varex Imaging's revenue was $844.60 million, an increase of 4.14% compared to the previous year's $811.00 million. Losses were -$70.30 million, 44.1% more than in 2024.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for VREX stock is "Strong Buy." The 12-month stock price target is $16.67, which is an increase of 38.11% from the latest price.
News
Varex Schedules Second Quarter Fiscal Year 2026 Earnings Release and Conference Call
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the second quarter of fiscal year 2026, following the clos...
Varex Imaging Transcript: Sidoti March Small-Cap Virtual Conference
X-ray imaging markets remain stable, with strong OEM relationships and growth in both medical and industrial segments. New factories in India and innovative photon counting technology are set to drive future revenue, while recent refinancing has improved financial flexibility.
Varex Imaging Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Business remains resilient amid geopolitical and tariff changes, with stable healthcare and industrial demand. China’s market has normalized, India facilities are ramping up for FY 2026-2028 growth, and photon counting technology is set to drive future margin expansion.
Varex Announces Successful Completion of Debt Refinancing
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced it has entered into a Credit and Guaranty Agreement (the “Credit Agreement”), dated as of March 13, 2026, whic...
Varex Management to Present in Upcoming Investor Conferences
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the following upcoming investor conferences. Oppenheimer's 36th Ann...
Varex Imaging Corporation to Redeem Its 7.875% Senior Secured Notes Due 2027
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) (the “Company” or “Varex”) today announced it has issued a notice of conditional full redemption of all of its outstanding 7.8...
Varex Imaging Transcript: AGM 2026
The meeting introduced board members, confirmed a quorum, and covered three proposals: board elections, executive compensation, and auditor ratification. All proposals passed, and stockholders could submit questions for live or later response.
Varex Imaging Earnings Call Transcript: Q1 2026
Q1 FY2026 revenue rose 5% year-over-year to $210 million, led by 17% growth in the industrial segment and stable medical performance. Non-GAAP EPS doubled to $0.19, and strong customer engagement and innovation are fueling a robust pipeline. Guidance for Q2 projects continued growth.
Varex Announces Financial Results for First Quarter Fiscal Year 2026
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter fiscal year 2026. Q1FY26 Summary Revenues $210 million G...
Varex Schedules First Quarter Fiscal Year 2026 Earnings Release and Conference Call
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the first quarter of fiscal year 2026, following the close...
Varex Imaging Transcript: CJS Securities 26th Annual "New Ideas for the New Year” Investor Conference
Management highlighted strong positions in medical and industrial X-ray markets, with growth driven by new products, India manufacturing, and photon-counting technology. Tariffs and past challenges have been addressed, and major investments are expected to yield significant revenue gains in cargo, Rad, and CT detector segments over the next few years.
Varex to Participate in CJS Securities 26th Annual New Ideas for the New Year Conference
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the CJS Securities 26th Annual New Ideas for the New Year Virtual C...
Varex Imaging Earnings Call Transcript: Q4 2025
Fourth quarter revenue grew 11% year-over-year, led by record Industrial sales and strong Medical demand. Full-year revenue rose 4%, with margin expansion and robust cash flow, despite tariff headwinds and a non-cash goodwill impairment. Gradual growth is expected in 2026.
Varex Announces Financial Results for Fourth Quarter and Fiscal Year 2025
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the fourth quarter and fiscal year 2025. Q4FY25 Summary Revenues $229 mill...
Varex Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the fourth quarter and fiscal year 2025, following the clo...
Varex Imaging Transcript: Small-Cap Virtual Conference
Medical and industrial segments are both positioned for growth, with China and new cargo systems driving demand. Tariff mitigation strategies and new India factories are enhancing supply chain resilience. Innovation in photon counting and nanotube technologies is progressing, while financial health is improving through debt reduction and cash generation.
Varex to Present at the Sidoti Small Cap Virtual Conference
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Sidoti Small Cap Virtual Conference. Management will be present...
Varex Imaging Earnings Call Transcript: Q3 2025
Third quarter revenue and gross margin exceeded guidance, driven by strong industrial demand and stable China sales after tariff relief. Non-GAAP EPS rose year-over-year, while a non-cash goodwill impairment led to a GAAP net loss. Q4 guidance anticipates growth in both segments.
Varex Announces Financial Results for Third Quarter Fiscal Year 2025
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the third quarter of fiscal year 2025. 3QFY25 Summary Revenues of $203 mil...
Varex Schedules Third Quarter Fiscal Year 2025 Earnings Release and Conference Call
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the third quarter of fiscal year 2025, following the close...
Varex Announces Non-intrusive Cargo Inspection Systems Orders Valued at $17 Million
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it has received orders for its high-energy non-intrusive cargo and vehicle inspection systems valued at a...
Varex Imaging Transcript: Jefferies Global Healthcare Conference 2025
Leads in X-ray imaging components, with strong medical and industrial presence and a focus on innovation. Recent results exceeded expectations, with normalized inventory and robust demand. Tariff mitigation includes supply chain diversification and new India plants, supporting growth in both medical and industrial markets.
Varex to Present at the Jefferies Global Healthcare Conference
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Jefferies Global Healthcare Conference in New York. Management ...
Varex Imaging Earnings Call Transcript: Q2 2025
Revenue grew 3% year-over-year to $213 million, with gross margin at 36% and strong cash flow. Tariffs are expected to reduce Q3 China sales by $20 million, but mitigation strategies and local manufacturing are underway. Guidance anticipates lower Q3 revenue and EPS.
Varex Announces Financial Results for Second Quarter Fiscal Year 2025
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2025. 2QFY25 Summary Revenues of $213 mi...